Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 506327, 8 pages
http://dx.doi.org/10.1155/2015/506327
Review Article

Systematic Review of the Use of Phytochemicals for Management of Pain in Cancer Therapy

1Medical Scientist Training Program, Mayo Clinic, Rochester, MN 55905, USA
2Department of Anesthesiology, CH du Forez, 42600 Montbrison, France
3Mayo Graduate School, Mayo Clinic, Rochester, MN 55905, USA
4Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN 55905, USA
5Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA

Received 10 August 2015; Accepted 1 October 2015

Academic Editor: Sung-Hoon Kim

Copyright © 2015 Andrew M. Harrison et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. H. J. van den Beuken-van Everdingen, J. M. de Rijke, A. G. Kessels, H. C. Schouten, M. van Kleef, and J. Patijn, “Prevalence of pain in patients with cancer: a systematic review of the past 40 years,” Annals of Oncology, vol. 18, no. 9, pp. 1437–1449, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. P. W. Mantyh, D. R. Clohisy, M. Koltzenburg, and S. P. Hunt, “Molecular mechanisms of cancer pain,” Nature Reviews Cancer, vol. 2, no. 3, pp. 201–209, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. G. M. Cragg and D. J. Newman, “Plants as a source of anti-cancer agents,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 72–79, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Anupama, G. Madhumitha, and K. S. Rajesh, “Role of dried fruits of Carissa carandas as anti-inflammatory agents and the analysis of phytochemical constituents by GC-MS,” BioMed Research International, vol. 2014, Article ID 512369, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. O. A. Fawole, S. O. Amoo, A. R. Ndhlala, M. E. Light, J. F. Finnie, and J. Van Staden, “Anti-inflammatory, anticholinesterase, antioxidant and phytochemical properties of medicinal plants used for pain-related ailments in South Africa,” Journal of Ethnopharmacology, vol. 127, no. 2, pp. 235–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. Harrison, N. M. Thalji, A. J. Greenberg, C. J. Tapia, and A. J. Windebank, “Rituximab for Non-Hodgkin's lymphoma: a story of rapid success in translation,” Clinical and Translational Science, vol. 7, no. 1, pp. 82–86, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. Y.-O. Son, K.-Y. Lee, J.-C. Lee et al., “Selective antiproliferative and apoptotic effects of flavonoids purified from rhus verniciflua stokes on normal versus transformed hepatic cell lines,” Toxicology Letters, vol. 155, no. 1, pp. 115–125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. K. A. Manu and G. Kuttan, “Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-κB mediated activation of bcl-2 in B16F-10 melanoma cells,” International Immunopharmacology, vol. 8, no. 7, pp. 974–981, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. K. S. Siveen, R. Surana, X. Dai et al., “Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1845, no. 2, pp. 136–154, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Korangath, W. W. Teo, H. Sadik et al., “Targeting glutamine metabolism in breast cancer with aminooxyacetate,” Clinical Cancer Research, vol. 21, no. 14, pp. 3263–3273, 2015. View at Publisher · View at Google Scholar
  11. A. Haywood, P. Good, S. Khan et al., “Corticosteroids for the management of cancer-related pain in adults,” Cochrane Database of Systematic Reviews, vol. 4, Article ID CD010756, 2015. View at Google Scholar
  12. P. Pratheeshkumar, C. Sreekala, Z. Zhang et al., “Cancer prevention with promising natural products: mechanisms of action and molecular targets,” Anti-Cancer Agents in Medicinal Chemistry, vol. 12, no. 10, pp. 1159–1184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Mahendran, G. Thamotharan, S. Sengottuvelu, and V. N. Bai, “Evaluation of anticonvulsant, sedative, anxiolytic, and phytochemical profile of the methanol extract from the aerial parts of Swertia corymbosa (griseb.) wight ex C.B. Clarke,” BioMed Research International, vol. 2014, Article ID 542385, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Venkatesan, E. Ji, and S. Y. Kim, “Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review,” BioMed Research International, vol. 2015, Article ID 814068, 22 pages, 2015. View at Publisher · View at Google Scholar
  15. R. H. Liu, “Potential synergy of phytochemicals in cancer prevention: mechanism of action,” Journal of Nutrition, vol. 134, no. 12, supplement, pp. 3479S–3485S, 2004. View at Google Scholar · View at Scopus
  16. M. F. Balandrin, J. A. Klocke, E. S. Wurtele, and W. H. Bollinger, “Natural plant chemicals: sources of industrial and medicinal materials,” Science, vol. 228, no. 4704, pp. 1154–1160, 1985. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” Annals of Internal Medicine, vol. 151, no. 4, pp. 264–269, 2009. View at Publisher · View at Google Scholar
  18. A. Liberati, D. G. Altman, J. Tetzlaff et al., “The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration,” Annals of Internal Medicine, vol. 151, no. 4, pp. W65–W94, 2009. View at Google Scholar · View at Scopus
  19. J. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, vol. 5, The Cochrane Collaboration, 2011.
  20. J. Babineau, “Product review: covidence (systematic review software),” Journal of the Canadian Health Libraries Association, vol. 35, no. 2, pp. 68–71, 2014. View at Publisher · View at Google Scholar
  21. Y.-J. Bao, B.-J. Hua, W. Hou, H.-S. Lin, X.-B. Zhang, and G.-X. Yang, “Alleviation of cancerous pain by external compress with xiaozheng zhitong paste,” Chinese Journal of Integrative Medicine, vol. 16, no. 4, pp. 309–314, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Belcaro, M. Hosoi, L. Pellegrini et al., “A controlled study of a lecithinized delivery system of curcumin (meriva) to alleviate the adverse effects of cancer treatment,” Phytotherapy Research, vol. 28, no. 3, pp. 444–450, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Brooker, S. Martin, A. Pearson et al., “Double-blind, placebo-controlled, randomised phase II trial of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration,” Radiotherapy and Oncology, vol. 79, no. 1, pp. 45–51, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Costa Fortes, V. Lacorte Recova, A. Lima Melo, and M. R. Carvalho Garbi Novaes, “Life quality of postsurgical patients with colorectal cancer after supplemented diet with agaricus sylvaticus fungus,” Nutricion Hospitalaria, vol. 25, no. 4, pp. 586–596, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Pommier, F. Gomez, M. P. Sunyach, A. D'Hombres, C. Carrie, and X. Montbarbon, “Phase III randomized trial of Calendula Officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer,” Journal of Clinical Oncology, vol. 22, no. 8, pp. 1447–1453, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Tröger, D. Galun, M. Reif, A. Schumann, N. Stanković, and M. Milićević, “Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial,” Deutsches Arzteblatt International, vol. 111, no. 29-30, pp. 493–502, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Pawar, R. S. Neve, S. Kalgane et al., “SAMITAL improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind phase II study,” Supportive Care in Cancer, vol. 21, no. 3, pp. 827–834, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Morazzoni, G. Petrangolini, E. Bombardelli, M. Ronchi, W. Cabri, and A. Riva, “SAMITAL: a new botanical drug for the treatment of mucositis induced by oncological therapies,” Future Oncology, vol. 9, no. 11, pp. 1717–1725, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. R. P. Harris, M. Helfand, S. H. Woolf et al., “Current methods of the U.S. Preventive Services Task Force: a review of the process,” American Journal of Preventive Medicine, vol. 20, no. 3, supplement 1, pp. 21–35, 2001. View at Google Scholar · View at Scopus
  30. C. Blomström-Lundqvist, M. M. Scheinman, E. M. Aliot et al., “Acc/aha/esc guidelines for the management of patients with supraventricular arrhythmias—executive summary. A report of the american college of cardiology/american heart association task force on practice guidelines and the european society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with naspe-heart rhythm society,” Journal of the American College of Cardiology, vol. 42, no. 8, pp. 1493–1531, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Bostwick, “Blurred boundaries: the therapeutics and politics of medical marijuana,” Mayo Clinic Proceedings, vol. 87, no. 2, pp. 172–186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Bolognini and R. A. Ross, “Medical cannabis vs. synthetic cannabinoids: what does the future hold?” Clinical Pharmacology & Therapeutics, vol. 97, no. 6, pp. 568–570, 2015. View at Publisher · View at Google Scholar
  33. R. Noyes Jr., S. F. Brunk, D. H. Avery, and A. Canter, “The analgesic properties of delta-9-tetrahydrocannabinol and codeine,” Clinical Pharmacology and Therapeutics, vol. 18, no. 1, pp. 84–89, 1975. View at Google Scholar · View at Scopus
  34. S. K. Aggarwal, G. T. Carter, M. Sullivan, C. ZumBrunnen, R. Morrill, and J. D. Mayer, “Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State,” Journal of Opioid Management, vol. 5, no. 5, pp. 257–286, 2009. View at Google Scholar · View at Scopus
  35. M. E. Lynch, J. Young, and A. J. Clark, “A case series of patients using medicinal marihuana for management of chronic pain under the canadian marihuana medical access regulations,” Journal of Pain and Symptom Management, vol. 32, no. 5, pp. 497–501, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Lissoni, G. Porro, G. Messina et al., “Morphine, melatonin, marijuana, magnolia and myrrh as the ‘five m’ schedule in the treatment of cancer pain and the possible dose-dependency of the antitumor and analgesic effects of the pineal hormone melatonin,” Anticancer Research, vol. 34, no. 10, pp. 6033–6034, 2014. View at Google Scholar
  37. R. Mechoulam and L. A. Parker, “The endocannabinoid system and the brain,” Annual Review of Psychology, vol. 64, pp. 21–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. M. Bostwick, G. M. Reisfield, and R. L. DuPont, “Clinical decisions. Medicinal use of marijuana,” The New England Journal of Medicine, vol. 368, no. 9, pp. 866–868, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. J. M. Bostwick, “MMA not support of medical marijuana legislation,” Minnesota medicine, vol. 97, no. 4, article 28, 2014. View at Google Scholar · View at Scopus
  40. G. Zareba, “Phytotherapy for pain relief,” Drugs of Today, vol. 45, no. 6, pp. 445–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. D. J. Baker, T. Wijshake, T. Tchkonia et al., “Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders,” Nature, vol. 479, no. 7372, pp. 232–236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. B. B. Jarvis, “Stachybotrys chartarum: a fungus for our time,” Phytochemistry, vol. 64, no. 1, pp. 53–60, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Cui, D.-S. Kim, and K.-C. Park, “Antioxidant effect of Inonotus obliquus,” Journal of Ethnopharmacology, vol. 96, no. 1-2, pp. 79–85, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. O. Kim, S. B. Han, H. W. Lee et al., “Immuno-stimulating effect of the endo-polysaccharide produced by submerged culture of Inonotus obliquus,” Life Sciences, vol. 77, no. 19, pp. 2438–2456, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. Y.-M. Park, J.-H. Won, Y.-H. Kim, J.-W. Choi, H.-J. Park, and K.-T. Lee, “In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus,” Journal of Ethnopharmacology, vol. 101, no. 1–3, pp. 120–128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. O. Kim, H. W. Park, J. H. Kim, J. Y. Lee, S. H. Moon, and C. S. Shin, “Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus,” Life Sciences, vol. 79, no. 1, pp. 72–80, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. S. E. Straus, W. S. Richardson, P. Glasziou, and R. B. Haynes, Evidence-Based Medicine: How to Practice and Teach EBM, Churchill Livingstone, Edinburgh, Scotland, 2005.
  48. J. R. Johnson, M. Burnell-Nugent, D. Lossignol, E. D. Ganae-Motan, R. Potts, and M. T. Fallon, “Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of thc:Cbd extract and thc extract in patients with intractable cancer-related pain,” Journal of Pain and Symptom Management, vol. 39, no. 2, pp. 167–179, 2010. View at Publisher · View at Google Scholar · View at Scopus